AI
| Followers | 73 |
| Posts | 3426 |
| Boards Moderated | 1 |
| Alias Born | 04/28/2004 |
Thursday, December 06, 2012 7:14:02 PM
CDKs / Seliciclib:
Not much thought on this drug, but let me point out a neat feature of seliciclib that shows why i was skeptical of targeting CDKs:
- as you note, CYCC says it hits CDK2, 7 and 9
- Cayman says it hits CDK2, 5, 7 and 1
- Enzo says it hits CDK1, 2 and 5
I guess the consensus is that it hits CDK2, with a dash of CDK1, 5, 7 and 9
Not much thought on this drug, but let me point out a neat feature of seliciclib that shows why i was skeptical of targeting CDKs:
- as you note, CYCC says it hits CDK2, 7 and 9
- Cayman says it hits CDK2, 5, 7 and 1
- Enzo says it hits CDK1, 2 and 5
I guess the consensus is that it hits CDK2, with a dash of CDK1, 5, 7 and 9
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
